These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 13677328)
21. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714 [No Abstract] [Full Text] [Related]
22. Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: a look at the clinical and pharmacological evidence. Lordkipanidzé M; Diodati JG; Pharand C Pharmacol Ther; 2009 Aug; 123(2):178-86. PubMed ID: 19426760 [TBL] [Abstract][Full Text] [Related]
23. [Clopidogrel as basic therapy in high-risk stroke patients]. Mattle HP Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694 [No Abstract] [Full Text] [Related]
24. Update on the use of antiplatelet agents in secondary stroke prevention. Jamieson DG J Natl Med Assoc; 2007 Mar; 99(3):306. PubMed ID: 17393957 [No Abstract] [Full Text] [Related]
25. [Clopidogrel: background information and use in clinical practice]. Ziegler BK; Rasmussen LH; Kristensen SD; Hildebrandt PR; Nielsen HK; Husted SE Ugeskr Laeger; 2003 Apr; 165(18):1859-63. PubMed ID: 12772393 [TBL] [Abstract][Full Text] [Related]
26. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Bhatt DL Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708 [TBL] [Abstract][Full Text] [Related]
27. New modalities and aspects of antiplatelet therapy for stroke prevention. Uchiyama S; Nakamura T; Yamazaki M; Kimura Y; Iwata M Cerebrovasc Dis; 2006; 21 Suppl 1():7-16. PubMed ID: 16479097 [TBL] [Abstract][Full Text] [Related]
34. Antiplatelet agents for secondary prevention of ischemic stroke. Majid A; Delanty N; Kantor J Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854 [TBL] [Abstract][Full Text] [Related]
35. Counting the true cost of antiplatelet therapy for stroke prevention. Morton JA; Newton J; Gray CS Age Ageing; 2005 May; 34(3):212-4. PubMed ID: 15863405 [No Abstract] [Full Text] [Related]
36. Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies. Mohammad RA; Goldberg T; Dorsch MP; Cheng JW Clin Ther; 2010 Dec; 32(14):2265-81. PubMed ID: 21353100 [TBL] [Abstract][Full Text] [Related]
37. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related]
38. Aspirin and clopidogrel resistance-a myth or reality: an update. Gupta S; Gupta MM Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315 [No Abstract] [Full Text] [Related]
39. Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week. Guha S; Sardar P; Guha P; Deb S; Karmakar R; Chakraborti P; Mookerjee S; Deb PK; De R; Dutta A; Chaudhuri U Indian Heart J; 2009; 61(2):173-7. PubMed ID: 20039503 [TBL] [Abstract][Full Text] [Related]
40. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial. Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]